• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Director Baird Jennifer A converted options into 2,667 shares and bought $4,174 worth of shares (10,000 units at $0.42), increasing direct ownership by 83% to 28,000 units (SEC Form 4)

    7/2/25 7:32:54 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care
    Get the next $ICU alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Baird Jennifer A

    (Last) (First) (Middle)
    C/O SEASTAR MEDICAL HOLDING CORPORATION
    3513 BRIGHTON BLVD., SUITE 410

    (Street)
    DENVER CO 80216

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    SeaStar Medical Holding Corp [ ICU ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    06/04/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock, par value $0.0001 per share(1) 06/04/2025 M 2,667(2) A $0 18,000(3) D
    Common Stock, par value $0.0001 per share 06/30/2025 P 10,000 A $0.4174 28,000(3) D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Unit (4) 06/04/2025 M 2,667 (5) (5) Common Stock, par value $0.0001 per share 2,667 $0 0(6) D
    Explanation of Responses:
    1. This Form 4 is being filed to report the vesting of certain restricted stock unit ("RSU") awards, the moving of unvested RSU awards previously reported in Table II to Table I and the open market purchase of shares of Common Stock.
    2. Reflects RSUs that upon vesting converted into shares of ICU common stock.
    3. The total includes 5,333 shares underlying RSUs that were previously reported in Table II.
    4. Each restricted stock unit represents a contingent right to receive one share of ICU common stock.
    5. As previously reported, on November 13, 2024, the reporting person was granted 8,000 RSUs, vesting in three approximately equal annual installments on the first, second and third anniversaries of June 4, 2024.
    6. The total does not include 5,333 shares underlying RSUs that are now reported in Table I.
    Remarks:
    /s/ David Green, as attorney-in-fact 07/02/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ICU alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ICU

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ICU
    Financials

    Live finance-specific insights

    See more
    • SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

      DENVER, May 07, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its first quarter financial results after market close on Wednesday, May 14, 2025, and host a webcast and conference call to discuss its financial results and business progress. Date/Time:Wednesday, May 14, 2025, at 4:30 p.m. ET / 2:30 p.m. MTWebcast:The live webcast and replay can be found here.Conference ID:2078693Dial-in numbers:1 (800) 715-9871 within the U.S. 1 (646) 307-1963 from outside the U.S.   A rep

      5/7/25 10:00:00 AM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

      DENVER, March 27, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today financial results for the three months and year ended December 31, 2024, and provided business updates on key initiatives. "Our significant accomplishment in 2024 position us well for a transformational year in 2025," said Eric Schlorff, SeaStar Medical CEO. "Last year, we not only received our first product approval for QUELIMMUNE and began our commercial launch, but we added 14 new clinical sites for our NEUTRALIZE AKI pivotal clinic

      3/27/25 4:05:00 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

      DENVER, March 24, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its fourth quarter and year-end 2024 financial results after market close on Thursday, March 27, 2025, and host a webcast and conference call to discuss its financial results and business progress. Date/Time:Thursday, March 27, at 4:30 p.m. ET / 1:30 p.m. PT  Webcast:The live webcast and replay can be found here.  Conference ID:2078693  Dial-in numbers:1 (800) 715-9871 within the U.S.   1 (646) 307-1963 from outside

      3/24/25 5:30:00 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care

    $ICU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Baird Jennifer A converted options into 2,667 shares and bought $4,174 worth of shares (10,000 units at $0.42), increasing direct ownership by 83% to 28,000 units (SEC Form 4)

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      7/2/25 7:32:54 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • Director Neuman John bought $14,396 worth of shares (40,000 units at $0.36), increasing direct ownership by 100% to 80,000 units (SEC Form 4)

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      6/27/25 6:00:07 AM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • Director Baird Jennifer A bought $12,815 worth of shares (10,000 units at $1.28) (SEC Form 4)

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      5/22/25 5:40:43 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care

    $ICU
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SeaStar Medical Announces Positive Nasdaq Listing Determination

      DENVER, July 02, 2025 (GLOBE NEWSWIRE) -- Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it has received confirmation from The Nasdaq Stock Market that the Company has evidenced compliance with the minimum $2.5 million stockholders' equity requirement and all other applicable criteria for continued listing on The Nasdaq Capital Market. Accordingly, the previously disclosed listing matter has been closed. "We are very pleased to have this hurdle behind us and can now turn our full attention to commercializing QUELIMMUNE and ou

      7/2/25 4:25:00 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • SeaStar Medical Reports Update on Nasdaq Listing Status

      DENVER, June 25, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU) a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today that it has undertaken a series of transactions to ensure compliance with Nasdaq's continued listing standards.   Last year on June 24, 2024, SeaStar Medical received a written notification from Nasdaq's Listing Qualifications Staff that it was not in compliance with the requirement to maintain a minimum market value of listed securities of $35 million as required by Nasdaq Listing Rule 5550(b)(2). After a hearing before the Nasdaq Heari

      6/25/25 8:05:00 AM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

      DENVER, June 20, 2025 (GLOBE NEWSWIRE) --  SeaStar Medical Holding Corporation (the "Company" or "SeaStar Medical") (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, today announced the pricing of a public offering of 6,153,847 shares of the Company's common stock (or pre-funded warrants in lieu thereof) and accompanying Series A warrants to purchase up to 6,153,847 shares of common stock and Series B short-term warrants to purchase up to 6,153,847 shares of common stock, at a combined offering price of $0.65 per share of common stock (or per pre-funded warrant in lieu thereof)

      6/20/25 12:10:04 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care

    $ICU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Medical Officer Chung Kevin converted options into 5,000 shares, increasing direct ownership by 12% to 48,184 units (SEC Form 4)

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      7/3/25 4:33:57 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • Chief Executive Officer Schlorff Eric converted options into 21,667 shares, increasing direct ownership by 28% to 98,517 units (SEC Form 4)

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      7/3/25 4:33:23 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • Director Baird Jennifer A converted options into 2,667 shares and bought $4,174 worth of shares (10,000 units at $0.42), increasing direct ownership by 83% to 28,000 units (SEC Form 4)

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      7/2/25 7:32:54 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care

    $ICU
    SEC Filings

    See more
    • SeaStar Medical Holding Corporation filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

      8-K - SeaStar Medical Holding Corp (0001831868) (Filer)

      7/2/25 4:59:10 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • SEC Form SCHEDULE 13G filed by SeaStar Medical Holding Corporation

      SCHEDULE 13G - SeaStar Medical Holding Corp (0001831868) (Subject)

      6/27/25 5:08:27 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • SEC Form 424B4 filed by SeaStar Medical Holding Corporation

      424B4 - SeaStar Medical Holding Corp (0001831868) (Filer)

      6/23/25 9:17:18 AM ET
      $ICU
      Medical/Dental Instruments
      Health Care

    $ICU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by SeaStar Medical Holding Corporation

      SC 13G - SeaStar Medical Holding Corp (0001831868) (Subject)

      11/14/24 5:35:52 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care